Merge Healthcare reported sales of $50.9 million in Q1, down from $63.6 million during the same period last year. However, net income was $300,000, which resulted in a negligible per-share gain but is an improvement over a net loss of $6.5 million last quarter.
The gain was made possible by refinancing the company’s debt and reducing other expenses.
“In Q1, Merge continued to see positive momentum in our operations,” said Merge CEO Justin Dearborn. “We’ve demonstrated strong cash flow by keeping our expenses under control, achieved positive net income and increased our adjusted EBITDA [$10.2 million in Q1].”
The improved outlook for Merge Healthcare follows a turbulent past few quarters. In August 2013, a leadership reconfiguration led to the resignations of board chairman Michael Ferro Jr., and board member Jeffrey Surges, according to a Crain’s Chicago Business report.
In January, Merge Healthcare announced a now-former employee in its eClinical division had falsified millions of dollars in customer contracts in order to increase his commissions, which caused the company’s stocks to slide 10 percent in the next day’s trading.
More Articles on Merge Healthcare:
Surescripts Adds 2 Dozen New EHR Vendors to Network
12 Recent Health IT Market Stories
Merge Healthcare Announces Employee Falsified Contracts, Shares Drop 10%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
